Stockreport

EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF companies regarding a potential strategic partnership to develop and commercialize its lead drug candidate, PrimeC, for Amyotrophic Lateral Sclerosis (ALS) These discu [Read more]